6-Br-5methylindirubin-3′oxime (5-Me-6-Bio) Targeting the Leishmanial Glycogen Synthase Kinase-3 (GSK-3) Short Form Affects Cell-Cycle Progression and Induces Apoptosis-Like Death: Exploitation of GSK-3 for Treating Leishmaniasis
International Journal for Parasitology - United Kingdom
doi 10.1016/j.ijpara.2009.04.005
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2009
Authors
Publisher
Elsevier BV